4.8 Article

A genome-wide screening uncovers the role of CCAR2 as an antagonist of DNA end resection

期刊

NATURE COMMUNICATIONS
卷 7, 期 -, 页码 -

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/ncomms12364

关键词

-

资金

  1. Spanish Ministry of Economy and Competitivity [SAF2010-14877]
  2. ERC
  3. Spanish Ministry of Education
  4. Juan de la Cierva Postdoctoral Grant
  5. EMBO short-term fellowship
  6. Danish National Research Foundation [DNRF125]
  7. Danish Council for Independent Research [DFF-1331-00262]
  8. Novo Nordisk Foundation [NNF16584]
  9. Lundbeck Foundation [R93-2011-8990] Funding Source: researchfish
  10. Novo Nordisk Fonden [NNF12OC0002290, NNF15OC0016584] Funding Source: researchfish
  11. The Danish Cancer Society [R124-A7785] Funding Source: researchfish

向作者/读者索取更多资源

There are two major and alternative pathways to repair DNA double-strand breaks: non-homologous end-joining and homologous recombination. Here we identify and characterize novel factors involved in choosing between these pathways; in this study we took advantage of the SeeSaw Reporter, in which the repair of double-strand breaks by homology-independent or -dependent mechanisms is distinguished by the accumulation of green or red fluorescence, respectively. Using a genome-wide human esiRNA (endoribonuclease-prepared siRNA) library, we isolate genes that control the recombination/endjoining ratio. Here we report that two distinct sets of genes are involved in the control of the balance between NHEJ and HR: those that are required to facilitate recombination and those that favour NHEJ. This last category includes CCAR2/DBC1, which we show inhibits recombination by limiting the initiation and the extent of DNA end resection, thereby acting as an antagonist of CtIP.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据